NCT04188184 is a NA clinical trial of Tranexamic Acid in Intraoperative Bleeding, sponsored by Assiut University.

Who is sponsoring NCT04188184?

NCT04188184 is sponsored by Assiut University.

What drugs are being tested in NCT04188184?

Interventions in NCT04188184: Tranexamic Acid, Epinephrine.

What condition does NCT04188184 study?

NCT04188184 studies Intraoperative Bleeding.

Is NCT04188184 still recruiting?

NCT04188184 is currently completed. Last updated 21 April 2020.

Last reviewed 2020-04-21 · How we verify

NCT04188184

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tranexamic Acid Versus Epinephrine During Exploratory Tympanotomy

Completed NA Last updated 21 April 2020

What this trial tests

NA trial testing Tranexamic Acid in Intraoperative Bleeding in 60 participants. Completed in 10 April 2020.

Timeline

4 December 2019

Primary endpoint
10 April 2020

10 April 2020

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	60
Start date	4 December 2019
Primary completion	10 April 2020
Estimated completion	10 April 2020
Sites	2 locations across Egypt

Drugs / interventions tested

Tranexamic Acid (Tranexamic Acid) — full drug profile →
Epinephrine (epinephrine) — full drug profile →

Conditions studied

Intraoperative Bleeding — all drugs for Intraoperative Bleeding →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Intraoperative Bleeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Exploratory tympanotomy is surgical access to the middle ear, made for diagnosis and management of unexplained conductive hearing loss, performed under an oto-microscope across the external auditory canal after tympanic membrane elevation to explore the middle ear structures

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Tranexamic Acid

Trials testing the same drug.

NCT07501884 — REDUCER Trial (TXA in Urethroplasty) · Phase 4 · not yet recruiting
NCT07460518 — Tranexamic Acid for Bleeding Reduction During TURP Surgery · Phase 4 · not yet recruiting
NCT07390799 — Prophylactic Tranexamic Acid in Low-Risk Repeat Cesarean Delivery: A Randomized Controlled Trial · NA · not yet recruiting
NCT07078942 — Prophylactic Intravenous Tranexamic Acid on Perioperative Blood Loss in Pregnant Women Undergoing Cesarean Section · Phase 4 · not yet recruiting
NCT07263841 — Comparison of Effectiveness of Tranexamic Acid Mesotherapy Versus Glutathione Mesotherapy in Post Burn Facial Hyperpigme · Phase 2 · active not recruiting

Other recruiting trials for Intraoperative Bleeding

Currently open trials in the same condition.

NCT06848764 — Lidocaine and Dexmedetomidine Infusions for Intraoperative Bleeding in Functional Endoscopic Sinus Surgery · NA · recruiting
NCT06427707 — The Effect of Adding Either Propofol or Ketamine to Magnesium and Lidocaine Infusions in Nasal Surgeries. · Phase 2, PHASE3 · recruiting
NCT06399445 — Measurement of Blood Loss in Adenotonsillectomy During General Anesthesia According to the Application of Nondepolarizin · Phase 4 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04188184 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 21 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04188184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing